Skip to main content
. Author manuscript; available in PMC: 2024 Aug 25.
Published in final edited form as: Pediatr Res. 2024 Jan 8;96(2):402–408. doi: 10.1038/s41390-023-02970-y

Table 1.

Characteristics of patient cohort.

Variable n % Mean SD
Demographics * Study arm
 Control 45 52%
 Intervention 42 48%
Sex
 Female 43 49%
 Male 44 51%
Race
 White/Caucasian 56 65%
 Black 9 10%
 Asian 7 8%
 More than 1 race identified 2 2%
Other/Unknown 13 15%
Antenatal Steroids (yes, %) 78 90%
Gestational age at birth, wk 27.2 2.5
Hormone Levels IGF-1 level (ng/mL)
 DOL 7 75 86% 26.1 9.6
 35 weeks PMA 62 71% 40.2 14.7
IGFBP-3 level (mcg/mL)
 DOL 7 77 89% 0.9 0.3
 35 weeks PMA 66 76% 1.3 0.4
Birth weight, length, OFC * Birth weight, grams (z-score) 87 942.9 (−0.2) 285.4 (0.8)
Birth length, cm (z-score) 87 34.5 (−0.2) 4.2 (1)
Birth OFC, cm (z-score) 87 24 (−0.5) 3.3 (1.6)
NICU Nutritional Intake * First week of life nutrition 87
 Kilocalorie intake/kg 95.9 15.8
 Protein intake/kg 4.2 0.4
 Kilocalories/kg from enteral feeds 22.8 18.7
 Protein g/kg from enteral feeds 0.7 0.7
NICU Comorbidities SNAP-II score, day 1–2 87 25 23.5
Hyperglycemia >180 mg/dL (# episodes) 87 1.7 2.4
Insulin treatment (# days) 87 1.1 2.4
Hypertriglyceridemia >300 mL/dL (# episodes) 87 0.3 0.6
Hypoglycemia <40 mg/dL (# episodes) 87 0 0.2
IVH, none/grade 1 73 84%
IVH, ≥grade 2 14 16%

PMA Postmenstrual age, DOL Day of life, SD Standard deviation, OFC Occipital-frontal circumference, SNAP-II Score for Neonatal Acute Physiology, IVH Intraventricular hemorrhage.

*

Portions of this data has been previously published.